ArticleTobacco induced diseases2026
The effects of nicotine exposure on depression: An integrative analysis combining network toxicology, molecular docking, and Mendelian randomization.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDepression is a globally prevalent affective disorder closely associated with environmental factors and neurological dysfunction, affecting over 300 million people worldwide and imposing a heavy burden on families and healthcare systems. As the core addictive bioactive component in tobacco, nicotine is intimately linked to an increased risk of depression, but its underlying molecular mechanisms remain unclear. This study aimed to explore the molecular mechanisms of nicotine-induced depression and identify the core molecular targets and pathways involved.
methodsThis study integrated network toxicology, molecular docking, and Mendelian randomization (MR). Nicotine's structure and SMILES were retrieved from PubChem for toxicity analysis via ADMETlab 3.0 and Protox3.0. Potential targets of nicotine and depression-related genes were screened from databases including GeneCards, OMIM, and ChEMBL. Common targets were obtained via Venny for PPI network construction, core target screening, GO/KEGG enrichment analysis, and molecular docking of the top 5 targets. MR verified causal associations with depression.
resultsNicotine exhibited significant neurotoxicity (probability=0.951), respiratory, hepatotoxic, and nephrotoxic effects. A total of 69 common targets were identified, including DRD2, CHRNA4, and STAT3. GO enrichment involved biological processes like excitatory postsynaptic potential and KEGG pathways such as cAMP signaling. Molecular docking showed favorable binding affinity (binding energies < -5.0 kcal/mol). MR confirmed that higher CHRNA4 expression in the Nucleus Accumbens increased depression risk (IVW, OR=1.02; 95% CI: 1.01-1.04, p=0.003).
conclusionsThis study demonstrated that nicotine exacerbates depressive-like behaviors by binding to core targets, including DRD2 and CHRNA4, and regulating dopaminergic and cholinergic pathways. These findings provide mechanistic insights for elucidating the underlying molecular mechanisms of nicotine-induced depression, while the identified targets and pathways offer potential directions for subsequent mechanistic validation and targeted studies of depression associated with nicotine exposure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.